AKT1 and colonic neoplasm: Our results showed Akt activity is greatly suppressed in wide type, p53-/- or PUMA-/- colon cancer cells following pazopanib treatment (Figure 2A and 2B), suggesting Akt signal is independent of or in the upstream of p53 and PUMA.